Sero-prevalence of anti-streptolysin ‘O’ antibodies at tertiary care hospital: A two year of prospective study

Abstract

Background: Streptococcus pyogenes (Group A Streptococcus/GAS) is the most prevalent human bacterial pathogens amongst streptocoocus species. It causes a wide range of suppurative infections in the respiratory tract and skin, life-threatening soft tissue infections, and certain types of toxin associated reactions. Some of these infections may, in addition, result in severe non-suppurative sequelae due to adverse immunological reactions induced by the infecting streptococci. As the diagnosis of non-suppurative infection caused Streptococcus pyogenes is only depends on immunological reaction, present study was carried out to see the sero-prevalence of Anti-streptolysin O antibodies in our region. Material & Methods: In the present prospective study was carried out in the Department of Microbiology under serology section at a tertiary care hospital from January 2015 to December 2016. Blood samples were taken from clinical suspicion cases of streptococcal infection. All samples were tested by using qualitative and semi-quantitative antibody detection method as per the standard guidelines. Results: A total of 1526 blood samples were collected and processed for the detection anti-streptolysin O antibodies. Out of which 92 (6.03%) were positive for ASO, among them 59 were from out door-patients department and 33 were from indoor-patients department. Out of 92 positive cases, 48 were males and 44 were female patients. Highest positive cases were found in the age group of 11-20 years (7.15), followed by the age group of 21-30 years where the prevalence was found to be 6.40%. Conclusion: The presence of elevated streptococcal antibody titers in such population, which probably reflects a high background prevalence of streptococcal infections, should be taken into consideration when evaluating the role of the group A streptococcus in non-purulent complications of infections.

Authors and Affiliations

Sunil Hatkar, Santosh Kotgire, Sufia Siddhiqui

Keywords

Related Articles

Inducible clindamycin resistance in staphylococcus aureus isolated from clinical samples at tertiary care hospital Ahmedabad

Introduction: Clindamycin is most commonly used drug in treatment of erythromycin resistant Staphylococcus aureus causing skin and soft tissue infection. In vitro routine tests for clindamycin susceptibility may fail to...

Isolation & study of multidrug resistant Acinetobacter from various clinical samples in a tertiary care hospital

Introduction: Nosocomial infections with Acinetobacter are being increasingly reported worldwide from debilitated& Critical care patients. Multidrug resistance among Acinetobacter are now a major cause of concern. So the...

PCR in tuberculosis: An extremely useful tool?

Introduction Tuberculosis is a global air borne infectious disease with significant increase in incidence and prevalence Conventional methods take longer time for diagnosis and drug susceptibility with less sensitivity a...

Prevalence of Nasal carriage of coagulase negative staphylococci and its antimicrobial susceptibility among ICU health care workers at a tertiary care hospital of Barabanki, UP

Introduction Health care workers HCW including medical as well as paramedical workers are a potential source of carrier of infection for the patients admitted in different intensive care units ICU The anterior nares are...

Seroprevalence of toxoplasmosis in antenatal women with bad obstetric history attending antenatal OPD in a tertiary hospital in Assam

Background: Toxoplasmosis has long since been incriminated with pregnancy wastage. In India, studies clearly show the rise in toxoplasma infection over last few decades. The present study is an effort to revisit the tren...

Download PDF file
  • EP ID EP305139
  • DOI 10.18231/2455-6807.2017.0006
  • Views 84
  • Downloads 0

How To Cite

Sunil Hatkar, Santosh Kotgire, Sufia Siddhiqui (2017). Sero-prevalence of anti-streptolysin ‘O’ antibodies at tertiary care hospital: A two year of prospective study. IP International Journal of Medical Microbiology and Tropical Diseases, 3(1), 24-26. https://europub.co.uk/articles/-A-305139